Frailty in Patients With Hematologic Malignancies and Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review

Documenti analoghi

• VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?
  di: Eva de Berranger, et al.
  Pubblicazione: (2024)
• Venetoclax‐Based Therapy for Early Relapse in Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Minireview
  di: Yufeng Du, et al.
  Pubblicazione: (2025)
• Successful Haplo‐Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia in a Child With Underlying Thrombocytopenia‐Absent Radius Syndrome: A Unique Case
  di: Sondus Al Sharidah, et al.
  Pubblicazione: (2026)
• The Effect of Interferon Type I Adjuvant Therapy on the Lifespan and Complications of Glioma Patients Undergoing Chemotherapy: A Systematic Review and Meta‐Analysis
  di: Nima Goudarzi, et al.
  Pubblicazione: (2026)
• Subsequent Primary Hematologic Malignancies in a 21‐Year‐Old Retinoblastoma Survivor: Case Report Study
  di: Elham Karimi, et al.
  Pubblicazione: (2025)